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ABSTRACT
Potential health benefits of blueberries may be due to vascular effects of anthocyanins which predominantly circulate in blood as phenolic acid
metabolites. We investigated which role blueberry anthocyanins and circulating metabolites play in mediating improvements in  vascular function
and explore potential mechanisms using metabolomics and nutrigenomics. Purified anthocyanins exerted a dose-dependent improvement of
endothelial function in healthy humans, as measured by flow-mediated dilation (FMD). The effects were similar to those of blueberries containing
similar amounts of anthocyanins while control drinks containing fiber, minerals, or vitamins had no significant effect. Daily 1-month blueberry
consumption increased FMD and lowered 24h-ambulatory-systolic-blood-pressure. Of the 63 anthocyanin plasma metabolites quantified,  14 and 17
correlated with acute and chronic FMD improvements, respectively. Injection of these metabolites improved FMD in mice. Daily blueberry
consumption led to differential expression (>1.2-fold) of 608 genes and 3 microRNAs, with Mir-181c showing a 13-fold increase in peripheral
blood mononuclear cells. Patterns of 13 metabolites were independent predictors of gene expression changes and pathway enrichment analysis
revealed significantly modulated biological processes involved in cell adhesion, migration, immune response, and cell differentiation. Our results
identify anthocyanin metabolites as major mediators of vascular bioactivities of blueberries and changes of cellular gene programs.
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INTRODUCTION
Cardiovascular aging is a dynamic process that goes along with endothelial dysfunction, intimal hyperplasia, and arterial stiffness and may lead to
arteriosclerosis and atherosclerosis.(1) In fact, the prevalence of coronary, peripheral, and cerebrovascular artery disease increase with age, may be
in the order of 25% in humans >75 years, and accounts for the majority of invalidity and mortality in older people.(2) Nutritional interventions are
promising approaches to slow cardiovascular aging.(3, 4) The protective effects of these approaches including the Mediterranean diet may be
mediated by a high fruit and vegetable intake and novel food bioactives consumed along with them.(3, 5) A growing body of nutritional science
highlights the complex mechanisms and pleiotropic pathways of cardiometabolic effects of different foods to support healthy cardiovascular aging.
(3) Therefore, there is a growing need to generate robust scientific evidence on the mechanistic and clinical effects of specific foods and in
particular the role of bioactive compounds in them that may mediate the effects.(7) To be able to understand the mechanisms-of-action it is
paramount to identify which bioactive compounds in fruits and vegetables are responsible for such beneficial effects and demonstrate causality
using accredited endpoints and understand how such compounds are absorbed, distributed, metabolized, and excreted in healthy humans. To date,
the most promising classes of food bioactives present in fruits and vegetables are polyphenols.(8, 9)
Blueberries are rich in polyphenols, in particular anthocyanins, but also contain other phenolic compounds in smaller amounts such as procyanidins,
flavonols and phenolic acids, as well as being a rich source of fiber, vitamins, and minerals.(10) Blueberries have initially been investigated due to
their potential beneficial effects on age-dependent decline in cognitive function(11) but were recently shown to improve cardiovascular function.
(12) Data from the Nurses’ Health Study II demonstrated that a high intake of blueberries and strawberries and the high intake of anthocyanins
associated with it (as calculated based on food frequency questionnaires) was inversely associated with the risk of myocardial infarction.(13) While
these data underscore potential real world relevance that anthocyanin intake with blueberries could lower cardiovascular risk, epidemiological data
inherently only provide associative evidence and are further limited by the lack of biomarkers of intake. Causality between anthocyanin intake in
berries and cardiovascular benefits in healthy humans has not been established so far. Furthermore, the biological mechanisms-of-action are not
fully understood and this may be due to the fact that anthocyanins are not present in circulation in relevant amounts but rather as low molecular
weight phenolic acid compounds which are the result of chemical and microbial degradation (14, 15). However, the role of the circulating
metabolites that reach the target organs (cardiovascular system) and can, therefore, only feasibly been regarded as the molecules causing the
biological effects is not defined so far.(9) The aims of this work were to investigate which role anthocyanins and their circulating metabolites play in
blueberry related vascular benefits, evaluate potential chronic effects, and explore their mechanisms-of-action.
 
METHODS
Human Studies
Four studies were conducted in healthy male volunteers (see Supplementary FIGUREs 1-4 for CONSORT study flow diagrams and study
protocols).
Human Study 1: In a double-blind, 5-arm randomized crossover controlled study, healthy volunteers (n=5) received the 5 treatments in random
order on 5 different days separated by one week of washout: control drink, control drink with fiber, control drink plus a mix of minerals and
vitamins, pure ACN (total ACN content of 160 mg, (Medox, Norway)), or a blueberry drink, made of 11 g of freeze-dried wild blueberry powder
(Wild Blueberry Association of North America) dissolved in 500 ml low nitratewater (TABLE 1). The amounts of fiber, minerals, vitamins, and
ACN were similar to the amounts present in the blueberry drink. The control was matched for flavor and color. Flow-mediated vasodilation (FMD)
was measured before (0 h) and at 1, 2, and 6 h post consumption.
Human Study 2: To investigate the dose-response of ACN, a randomized, controlled double-blind crossover trial was conducted (n=10). FMD was
measured at baseline before (0 h), at 2, and 6 h post consumption of ACN capsules (0 [control], 80, 160, 240, 320, or 480 mg ACN) on 6 different
days with one week wash-out between study days.
Human Study 3: An uncontrolled, single arm, single blind pilot study was performed to investigate the timecourse of the chronic effects of
blueberry on FMD. Volunteers (n=5) had 11g of blueberry powder, equivalent to 100g fresh blueberries, and containing 362mg total (poly)phenols
dissolved in 500 ml water bi-daily over 28 days, and FMD was measured at baseline, day 7, 14, 21, and 28.
Human Study 4: An acute-on-chronic 2-armed, double-blind, parallel randomized controlled trial was conducted (n=40, 20 in each arm) comparing
effects of wild blueberry drink (11 g blueberry powder, bi-daily) with matched control drinks (11 g powder, bi-daily) over 28 days. The primary
13/02/2019 jgbs(1).html
file:///C:/Users/vl918249/OneDrive%20-%20University%20of%20Reading/Publications/Blueberry_Journal%20of%20Gerontology_%20Biological… 3/13
outcome was improvement in FMD. Secondary endpoints were pulse-wave-velocity (PWV) and aortic augmentation index (AIX). and 24h-
ambulatory-blood-pressure (BP) was taken in a sub-population n=22). Measurements were taken on day 1 (baseline) and after 28 bi-daily
consumption at 0 and 2 h. Blood samples were drawn at all timepoints to measure plasma blueberry (poly)phenols and their metabolites. Blood
lipids (triglycerides, total cholesterol, HDL, LDL), glucose and routine clinical lab parameters were also determined. To explore potential
mechanism-of-action, mRNA and miRNA analyses were performed on peripheral blood mononuclear cells (PBMC) isolated from blood samples
that were collected after an overnight fasting period from 10 volunteers at the beginning and the end of the 28-day period of blueberry consumption.
 
Animal study
To prove the bioactivity of circulating phenolic acid metabolites, a 3-armed randomized double-blinded crossover study was carried out in ten 6-
week old male C57BL/6 mice with a 7-day wash-out period. The interventions were plasma (poly)phenol metabolite mixes comprising of
metabolites that correlated with human FMD acutely, chronically (adjusted for human equivalent dose according to the FDA guidelines (16);
TABLE 2B), and vehicle control (0.9% saline solution matched for methanol content at 5.8%). Mice were anesthetized with isofluran, and FMD
measured as previously published(17) before and after blinded administration of 100 μl through intracardiac injection. The analyses of ultrasound
images were performed by an operator blinded to allocation of treatments. The metabolites were purchased or synthesized(18), dissolved in
methanol and diluted with saline. Animal procedures were approved by the local authorities (84-02.04.2014.A312) at Duesseldorf University.
 
Vascular measurements
All vascular measures were performed by a trained researcher in a temperature-controlled room after a period of 15 minutes rest as detailed below.
FMD of the brachial artery was measured as previously described(19) using a 12 MHz transducer (Vivid I, GE Healthcare, Berlin, Germany) with
automatic edge-detection software (Brachial Analyzer, Medical Imaging Applications, Iowa City, IA, USA). A single trained operator performed the
analysis of all images within a single study. Office BP (mean of 2nd and 3rd measurements) was taken using an automated clinical digital
sphygmomanometer (Dynamap, Tampa, FL, USA).  24 h ambulatory BP measurements were performed on day 1 and day 28, using a Tonoport V
monitor (GE Healthcare, Berlin, Germany). PWV and AIX were measured by applanation tonometry using the SphygmoCor® (SMART medical,
Gloucestershire, UK) system determined from measurements taken at the carotid and femoral artery as previously described.(4)
 
Biochemical analysis
The blood samples collected in EDTA/heparin tubes were spun (1,700xg; 15 min; 4ºC) immediately after collection. Samples for (poly)phenol
analysis were spiked with 2% formic acid. All samples were aliquoted and frozen at -80°C until analysis. Screening clinical parameters including
total, LDL and HDL-cholesterol, triglycerides (enzymatic photometric assay; RocheDiagnostics), HbA1c, glucose (hexokinase assay) and whole
blood count (flow cytometry; Sysmex) were measured using standard techniques by the Institute for Clinical Chemistry, University Hospital
Düsseldorf, Germany.
 
 
 
Nutrient and (poly)phenol analysis of blueberry interventions
Nutrient analysis was performed by Medallion Labs (Minneapolis, US) using standard procedures. (Poly)phenol analysis of blueberry interventions
was performed as previously described.(10)
 
UPLC-Q-TOF MS analysis of plasma (poly)phenols
Plasma and urinary analysis of (poly)phenol metabolites was performed using microelution solid phase extraction coupled with UPLC-Q-TOF MS
and authentic standards for quantification as previously described.(20)
 
Gene expression analyses
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Peripheral blood mononuclear cells (PBMC) isolation: PBMCs were isolated from whole blood using BD Vacutainer tubes (Becton Dickinson,
Franklin Lakes, USA). Blood samples were collected after an overnight fasting period from 10 volunteers at the beginning and the end of the 28-day
period of consumption of 11 g of freeze-dried wild blueberry powder dissolved in 500 mL low nitrate water twice a day. Eight mL of blood
collected into BD Vacutainer tubes were immediately centrifuged at room temperature in a horizontal rotor for 20 min at 1,500xg. The cell layer was
collected and wished twice with sterile PBS with centrifugation at 300xg for 10 min between each washing step. The obtained pellet of PBMCs was
immediately frozen at -80°C and kept at this temperature until use.
 
Total RNA extraction: The PBMCs were lysed using lysing buffer solution from the RNeasy Micro Kit (Qiagen, Hilden, Germany). Total RNA
extraction has been performed using RNeasy Micro Kit as recommended by the manufacturer. RNA quality and quantity were checked by 1%
agarose gel electrophoresis and by the determination of the absorbencies at 260 and 280 nm on NanoDrop ND-1,000 spectrophotometer (Thermo
Scientific, Wilmington, DE, USA). The total RNA were stored at -80°C until used.
Microarray analysis: Total RNA (50 ng per sample) for 20 RNA samples  (10 from the volunteers at the beginning and 10 at the end of the 28-day
study period) was amplified and fluorescently labelled to produce Cy5 or Cy3 cRNA using the Low Input Quick Amp Labeling two color Kit
(Agilent, Santa Clara, USA) in the presence of spike-in two colors control as recommended by the manufacturer. After purification, 825 ng of
labeled cRNA were hybridized onto G4845A Human GE 4x44K v2 microarray (Agilent, USA) according to the manufacturer’s instructions. The
G4845A Human GE 4x44K v2 microarray contains 27958 Entrez Gene RNAs sequences. After hybridization, microarrays were scanned with
Agilent G2505 scanner (Agilent, USA) and data were extracted with Feature Extraction software (Agilent, USA) using linear and Lowess
normalization. Genespring GX10 software (Agilent, Santa Clara, CA, USA) was used to quantify the signal and background intensity for each
feature and to substantially normalize the data by the 75th percentile method. Statistical analyses were performed using Genespring GX10 software
to identify differentially expressed genes using Student’s t test and the probability values were adjusted false discovery rate to eliminate false
positives. Genes with FDR corrected p<0.05 and with a fold change >1.2 were referred to as differentially expressed genes (608). A gene list was
chosen based on strict criteria to perform a multivariate analysis on plasma (poly)phenol concentrations. At first, the coefficient of variation of fold
change expression was calculated between individuals where genes with less than 20% variation were designated resulting in a list of 152 genes. A
fold change cut-off of at least 1.3 was chosen resulting in 20 remaining genes (Figure 3A). Next, a Pearson correlation followed by stepwise
multivariate linear regression analysis of metabolite concentrations against the top 20 selected genes was performed. The analysis was executed 20
times, inserting every-time one gene against the 63 metabolites.
miRNA expression analysis: The impact of blueberry consumption on the expression of miRNAs was analyzed using Human miRNA (V3) 8x15K
microarrays (Agilent, Santa Clara, USA). MiRNAs were labeled using miRNA labeling and hybridization kit from Agilent technologies (Agilent,
Santa Clara, USA) as recommended by the manufacturer. Briefly, 100 ng of each total RNA sample were treated with calf intestinal phosphatase for
30 min at 37°C before denaturing the samples using pure DMSO at 100°C for 5 min and rapid transfer in an ice water bath to prevent RNA
reannealing. RNA samples were labeled with pCp-Cy3 using T4 RNA ligase by incubation at 16°C for 2 h. After purification with microBioSpin
columns, labeled samples were hybridized to Agilent human miRNA microarrays. Hybridizations were performed for 24 h at 55°C after which  the
microarrays were washed in GE Wash Buffer 1 (Agilent, Santa Clara, CA, USA) and GE Wash Buffer 2 (Agilent, Santa Clara, CA, USA) for 5 min.
Following washing step, the microarrays were scanned with Aligent Microarray Scanner (Agilent, Santa Clara, CA, USA). The scanned images
were analyzed using Feature Extraction Software (Agilent, Santa Clara, CA, USA). Genespring GX10 software (Agilent, Santa Clara, CA, USA)
was used to quantify the signal and background intensity for each feature and to substantially normalize the data by the 75th percentile method. The
statistical significance was the corrected ratios of hybridization signal intensity between blueberry-exposed samples and control samples. miRNAs
selected by these criteria are referred to as the “differentially expressed miRNAs”.
Biological interpretation: to extract maximum biological information of differentially expressed genes, together with gene ontology (biological
processes) and gene networks, genes were also classified according to their role(s) in cellular or metabolic pathways using Kyoto Encyclopedia of
Genes and Genomes (KEGG) (http://www.genome.jp/kegg/pathway.html) and Metacore (https://portal.genego.com) databases. Gene network
interactions were based on data mining tools where a score was given to every genes occurring in the same research abstracts. Potential transcription
13/02/2019 jgbs(1).html
file:///C:/Users/vl918249/OneDrive%20-%20University%20of%20Reading/Publications/Blueberry_Journal%20of%20Gerontology_%20Biological… 5/13
factors involved in the regulation of differentially expressed genes were searched using network algorithms for transcription factors development in
Metacore software. Potential target genes of miRNA were identified using miRWalk database (http://www.umm.uni-
heidelberg.de/apps/zmf/mirwalk/).
Power calculation and statistical analyses
FMD was defined as the primary outcome. Based on previous intervention studies with blueberries, we expected a change in FMD by 1-2%.(12)
The intra- and inter-individual variability for FMD measurements established in our laboratory are 0.9% (standard deviation of difference between
repeated FMD measurements in n=20 middle aged healthy subjects, unpublished) and 1% (standard deviation within a group of healthy old
subjects).(21) Study 1-3: Assuming a SD of difference between repeated FMD measurements of 0.9%, intra-individual measurements in 5 and 10
experimental subjects would provide sufficient power to detect an absolute change in FMD of 1.5% and 0.9% (two sided a of 5%, power = 0.80).
Study 4: Assuming a SD of change in FMD of 1%, 20 experimental and 20 control subjects would provide sufficient power to detect an absolute
change in FMD of 0.9% (two sided a of 5%, power = 0.80). Changes in FMD values were compared to control by one-way repeated measurements
ANOVA (study 1-2) and are presented as mean values and 95% confidence intervals. In study 3, FMD values were compared to baseline by one-
way repeated measurements ANOVA. In study 4, changes in FMD values at 2h, 1 month, and 1 month/2h relative to baseline values at day 1/0h
were compared to control by one-way repeated measurements ANOVA (study 1-2) and are presented as mean values and 95% confidence intervals.
Sample size calculations for the mouse study were based on our previously described method (17) to detect significant FMD changes with a power
of 0.8 and error probability of 0.05. Changes in % FMD in between control and acute/chronic mixes were performed using one-way repeated
measurements ANOVA with Dunnett’s post-hoc test.  Correlations are presented as Pearson’s r for normal distribution and as Spearman for non-
normal distribution. Analyses were performed in Prism 6 and 7 and SPSS 20 (IBM). See above sections for microarray analyses.
 
RESULTS
The characteristics of the healthy volunteers (mean age 33±6 years [study 4]) are shown in Supplementary TABLE 1.
Anthocyanins are major contributors of endothelial function improvement after blueberry consumption
We first evaluated the potential role of anthocyanins as major bioactives in blueberries to increase endothelial function. In a randomized crossover
study (Study 1; Supplementary FIGURE 1), we compared the effects of fiber, minerals and vitamins, and anthocyanins with the effects of
blueberries containing the compounds in similar amounts on flow-mediated vasodilation (FMD). Our present results demonstrated that neither the
vehicle control drink, the control with fiber, nor the control with minerals and vitamins in similar amounts as present in 100g of fresh blueberries
(TABLE 1) had a significant effect on FMD at 2 and 6h post-consumption (FIGURE 1A). More importantly, 160 mg of pure anthocyanins was
sufficient to increase FMD in a similar magnitude as blueberries containing 150 mg anthocyanins did.
 
Pure anthocyanins dose-dependently increase endothelial function
To further evaluate the causal role of anthocyanins in the mediation of vascular effects of blueberries, we performed dose-response experiments with
pure anthocyanins (Study 2span style="font-family:'Times New Roman'; font-weight:bold">; Supplementary FIGURE 2). Our data demonstrate a
clear dose-dependent increase in FMD at 2 and 6 h after consumption of pure anthocyanins (0-480 mg), respectively (FIGURE 1B). The amount to
achieve half-maximal FMD improvements (ED50) was 131 mg (95%CI:59,290 mg) and 150 mg (95%CI:78,290 mg) ACN at 2h and 6 h,
respectively. The top of the sigmoid curve fit indicated maximal FMD increases of 1.3% (95%CI:0.8,1.9%) and 1.1% (95%CI: 0.6,1.5%),
respectively. This was similar to our previously published dose-response study with blueberries.(12) The current analysis of dose-response data
from the previously published study(12) is shown in FIGURE 1C. It showed that the amount of anthocyanins in blueberries to achieve half-
maximal FMD improvements was 120 mg and did not significantly differ from pure anthocyanins. The top of the sigmoid curve fit indicated a
maximal FMD increases after blueberries of 2.1% (95%CI:1.8,2.5%) which is significantly larger than achieved with anthocyanins when consumed
alone.
 
Daily blueberry consumption leads to sustained effects on endothelial function and blood pressure
We then evaluated (a) which anthocyanin metabolites circulate in blood and may, therefore, qualify as bioactives causing the vascular functional
effects, and (b) whether acute effects translate into sustained effects with a potential to impact vascular health.
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In a pilot open label study (Study 3; Supplementary FIGURE 3) to evaluate the timecourse of chronic effects, we administered blueberries
containing 150 mg ACN bi-daily (300 mg/day) over one month and measured FMD every week in the morning after over night fasting. FMD
significantly increased already after one week, increased further after 2 weeks, and plateaued thereafter (FIGURE 2A). This suggests that at least 2
weeks of daily blueberry consumption are necessary to achieve a sustained improvement in endothelial function that persists after overnight fasting.
We then performed a one month randomized controlled intervention study (Study 4; Supplementary FIGURE 4) with additional secondary end-
points including 24-h-blood-pressure-measurements, AIX, PWV, and blood lipids, and detailed metabolomics analyses (Supplementary TABLE
2). The very first (acute) consumption of blueberry containing 150 mg of ACN significantly increased FMD by 1.5% (95%CI:0.6,2.3%) at 2 h post-
ingestion as compared to control (FIGURE 2B). After 28 days of bi-daily consumption, FMD was significantly increased after overnight fasting in
the wild blueberry group as compared to control by 2.3% (95%CI:1.4,3.2%). Interestingly, no further improvement in FMD was observed when
blueberries were acutely consumed on day 28 (acute-on-chronic; 0.3% [95%CI:-1.3,0.6%]) suggesting a saturation of effect indicating that acute
and chronic effects may be mediated via similar pathways.
The improvement in FMD was accompanied by a lowering of 24h-SBP (-5.6 mmHg [95%CI:-0.2,-11.1mmHg)]. Changes in 24h-DBP were not
significantly different from control (-5.5 mmHg [95%CI:-13.0,1.9 mmHg)]. No changes were seen with respect to PWV, AIX, or blood lipids in our
present study.
 
Acute and chronic blueberry effects are linked to circulating anthocyanin metabolome
To identify potential mediators of vascular effects, we performed a metabolomics analysis of circulating anthocyanin metabolites. A total of 63
phenolic metabolites were quantified in plasma taken from subjects after blueberry at 2h after first dose and after 1 month of bi-daily consumption
after an overnight fasting. Most of the metabolites were conjugated and non-conjugated phenolic acid derivatives, with only 3 of them being
flavonoid derivatives (see Supplementalry TABLE 2; data published elsewhere (22)). To link the circulating metabolites with vascular effects, we
performed univariate correlation analyses with the increases in FMD at 2 h and after 28-day consumption of blueberry and all individual plasma
metabolites (TABLE 2A). Fourteen phenolic metabolites significantly correlated with the acute effects and 21 with the chronic responses, with 9 of
them correlating with both acute and chronic responses.
 
Anthocyanin metabolites lead to endothelial function improvements when injected into a translational experimental model
To demonstrate the biological activity of the circulating ACN metabolites that correlated with the FMD responses in the human study (Study 4), we
facilitated a translational animal model that allows the measurement of FMD in living mice.(17) We assessed FMD in crossover study in 10
anesthetized mice before and at 15 min after injection of mixtures of the anthocyanin metabolites that were significantly correlated with acute and
chronic blueberries effects in study 4 or vehicle (TABLE 2B). Both metabolite mixes led to significant increases in FMD over vehicle (‘acute’-
metabolites: 8.7% [95%CI:3,15%]; ‘chronic’-metabolites: 8.3% [95%CI:2,14%]; FIGURE 2C).
Gene and miRNA expression changes linked with chronic consumption of blueberries
To gain insight into the nutrigenomic effect of chronic blueberry consumption, we performed exploratory gene expression analyses on PBMCs from
a subgroup (n=10) of the subjects participating in Study 4 comparing samples taken at baseline before and after having received blueberries over 28
days. The analyses showed that 608 genes were significantly differentially expressed (Supplementary FIGURE 5), with 357 genes up-regulated
and 251 identified as down-regulated with fold-changes varying from -1.58 to 1.61 (see FIGURE 3A for top 20). A homogenous fold change
expression across all ten individuals was observed with a minor variation in volunteer 1 for a subset of the genes (Supplementary FIGURE 5). To
evaluate the biological significance of the nutrigenomic data, a functional annotation of the 608 genes according to biological processes (gene
ontology) was performed. Gene network analysis was conducted to investigate gene-gene interactions. Among the 35 significant gene networks
identified, 11 are known to be involed in the regulation of chemotaxis and inflammation/immune response, 9 in cell adhesion and cytoskeleton
organization, and few networks regulating signal transduction, apoptosis, or development. Together with gene network analyses, pathway
enrichment analyses using KEGG and Metacore databases showed that among the most overrepresented pathways identified are those involved in
the regulation of cell adhesion, cell migration, inflammation, and cell differentiation processes (FIGURE 3A, Supplementary FIGURE 6).
 
13/02/2019 jgbs(1).html
file:///C:/Users/vl918249/OneDrive%20-%20University%20of%20Reading/Publications/Blueberry_Journal%20of%20Gerontology_%20Biological… 7/13
Together with the impact of blueberry polyphenol compounds on the expression of genes, we also analyzed their impact on expression of small non-
coding RNA, microRNA, involved in the post-transcriptional regulation of gene expression. Our nutrigenomic study identified 3 differentially
expressed miRNA in PBMCs of the volunteers consuming blueberries for 1 month: miR-181c-3p*, miR-126-5p*, miR-30c-5p (Supplementary
TABLE 3). The most striking finding was the 13-fold increase in expression of miR-181c. With the aim to retrieve potential biological effects of
modulation of the 3 miRNAs, we identified target genes of these miRNAs using the MirWalk database and performed network and pathway
analyses. Our comparison of differentially expressed genes with potential target genes of differentially expressed miRNAs revealed 69 genes in
common. This observation suggests that 11% of differentially expressed genes could be regulated at post-transcriptional level by the miRNAs.
Bioinformatic analyses to identify pathways and networks in which target genes are involved in have shown that among the most over-represented
ones are those involved in the regulation of focal adhesion, chemotaxis, cytoskeletal reorganization, cytokine-cytokine interactions, cellular
development but also lipid absorption, accumulation and excretion (FIGURE 3B, Supplementary FIGURE 6).
 
Metabolites predict expression changes in the top 20 selected genes
One third (n=21) of the quantified 63 metabolites showed significant correlation with improvements in FMD. To explore whether circulating
blueberry derived phenolic metabolites might be responsible for the changes in gene activity in PBMCs, a correlation followed by a stepwise
multivariate analysis was performed on a selection of top 20 genes with inter-individual variability less than 20%. From these top 20 genes, 15 are
involved in processes of inflammation or have a functional link to cardiovascular disease development. Twelve metabolites were identified as
significant independent predictors for changes in expression of the 20 genes (FIGURE 3A). Notably, the R2 of the individual multivariate linear
regression models including sets of metabolites being significant independent predictors of gene changes were 0.73-0.99 suggesting that 73-99% of
the variability in gene expression changes were explained by the metabolites. Two of the 12 metabolite independent predictors of gene expression
changes (namely quercetin 3-O-ß-D-glucuronide and homovanillic acid) positively correlated with improved human vascular function and were also
part of the polyphenol mix that significantly increased FMD in mice.
 
DISCUSSION
While blueberries contain many potentially ‘healthy’ bioactive molecules including vitamins, fibre, and minerals, our present results demonstrate
that anthocyanins are major bioactive compounds in blueberry that can account for the increases in endothelial function after blueberry
consumption. Our data demonstrate for the first time that purified anthocyanins cause dose-dependent improvements in endothelial function. The
comparison of pure anthocyanins dose-responses experiments with the previously obtained results with anthocyanin-rich blueberries (12) supports
that the majority of blueberry effects can be explained by anthocyanins but also indicate that the beneficial effects of blueberries are still larger than
achieved with the consumption of anthocyanins alone. This may be due to other blueberry (poly)phenols likely chlorogenic acids, which have been
previously shown to be capable of inducing favorable effects on endothelial function.(23) The amounts of vitamins, fibres, and minerals but also the
amount of flavanols (3 mg of flavanol monomers)(24) present in blueberries were too low to exert significant effects. However, we cannot discard
possible synergistic and/or antagonistic effects of components when consumed as a whole food, rather than individual compounds, as well as matrix
effects affecting the liberation or absorption of anthocyanins from blueberries, which have been previously described to play a role in the context of
flavanols.(25)
 
We also report for the first time in healthy adults that chronic blueberry consumption leads to a significant sustained improvement in endothelial
function and lowering of 24-h-SBP. A few studies in at-risk populations, however, have demonstrated a reduction in blood pressure after blueberry
consumption.(26) The potential clinical relevance of the findings is underscored by the fact that the lowering of blood pressure in the magnitude
observed in our study of 5 mmHg is similar to what is commonly observed in clinical studies with blood pressure lowering medication (e.g. ACE
inhibitors) in patients.(27) Taken together, our data demonstrate that blueberries not only acutely and transiently improve endothelial function (12)
but also induce sustained improvement in endothelial function and SBP after repetitive consumption over 1 month.
 
The molecular mechanisms-of-action of blueberries have still not been fully characterized and this may be due to the fact that only recently
significant advances in the understanding of the absorption and metabolism of anthocyanins and blueberry polyphenols were made indicating that,
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for instance, anthocyanins primarily circulate as phenolic metabolites.(12, 15) However, most clinical studies with cardiovascular outcomes have
not reported plasma or urine levels of circulating polyphenol metabolites in the participants. In a targeted metabolomics approach, we identified here
in healthy humans a panel of circulating metabolites that correlated with vascular FMD responses and demonstrated in a translational model that
these metabolites are indeed bioactive and can improve FMD after injection. Importantly, these metabolites do not represent metabolites specific for
anthocyanins and are common metabolites of other common dietary (poly)phenols.(9) A limitation of the present work is that we did not quantify
parent anthocyanins and their phase II metabolites. However, we believe that such results would likely not impact the outcomes of our present work
as the majority of anthocyanins are transformed into low molecular weight phenolic metabolites, which we quantified in this work. Intact
anthocyanins are present in very low concentrations in plasma, and typically represent less than 1% of the anthocyanin metabolome (12,15).
However, despite almost negligible absorption, we cannot discard that intact anthocyanins may also contribute to the effects observed here.
 
Future work is needed to dissect if it is one or several of the metabolites or combinations of metabolites that mediate the effects and if the individual
metabolites act via the same or different potentially synergistic mechanism(s). The investigation of structure-function relationships with these
candidate metabolites may help to identify the molecular target structure and investigate potential class effects. Many (poly)phenols share similar
phase II and gut microbiome derived metabolites, and similar metabolites have been observed to correlate with FMD after consumption of coffee
(23) and cranberries (28). Furthermore, whether these effects, slow or even reverses components of cardiovascular aging itself and can increase
healthspan or longevity remains to be determined. Future randomized controlled trials in larger populations including older subjects with relevant
clinical endpoints will answer this question.
 
Identifying molecular targets of polyphenol has proven to be a real challenge due to the complex mechanisms and pleiotropic pathways of
cardiometabolic effects of different foods. We here used an exploratory nutrigenomic approach aiming at identifying gene networks in circulating
mononuclear cells that were modulated by blueberry consumption in healthy humans and explored which gene and expression changes correlate
with circulating phenolic metabolites and vascular responses. It is a limitation of this approach that gene expression changes were investigated in
blood cells and not endothelial cells. However, immune responses, mediated by both circulating and resident leukocytes,(29) play
pathophysiological roles in the development and progression of CVD, including neutrophil recruitment, coronary atherosclerotic plaque
development and stability, heart failure, and endothelial dysfunction.(30, 31) A few studies have proposed molecular mechanisms-of-action of other
(poly)phenols in vitro and in vivo using nutrigenomic approaches.(32) These studies suggest that dietary (poly)phenols exert anti-inflammatory
properties by binding to molecular targets in human cells making them attractive candidates for dietary CVD prevention strategies. Our present data
corroborate these overall observations and add to the current body of knowledge by supplying in vivo data on nutrigenomic effects of blueberries
and link these with anthocyanin-metabolites in healthy humans. Among the significant gene networks identified from genes whose expression was
affected by blueberry, one third is involved in the regulation of immune response and inflammation. This observation suggests that blueberry
consumption can modulate inflammatory cellular processes of PBMCs that represent cellular targets of vascular function maintenance. The fact that
we also identified circulating anthocyanin metabolites in plasma as strong predictors of expression changes in the most overexpressed genes with
the majority being involved in inflammation suggest that these metabolites may play a mechanistic role in the mediation of effects. Only 2
metabolites correlated both with vascular function improvements and gene expression changes indicating that the mechanism by which anthocyanin
metabolites modulate vascular function and PBMC expression changes may differ and the interaction is likely complex. We also observed
significant changes in the expression of 3 micro RNAs. The little data available for miR-30c-5p and miR-181c-3p suggests that they could play a
role in cancer development but a possible link with cardiovascular disease remains to be determined. miR-126-5p was described as being involved
in enhancing the inflammatory responses of monocytes(33) or showing increased expression in patients with carotid artery disease(34) and acute
pancreatitis.(35) Taken together, our nutrigenomic data showed that blueberry consumption can modulate the expression of genes and miRNA
towards an anti-inflammatory and CVD protective profile, revealing new molecular targets that may be underlying the health properties of berries.
 
In conclusion, our results demonstrate a key role of anthocyanin metabolites in the mediation of biological activities of blueberries that could
contribute to healthy cardiovascular aging. We provide further scientific evidence that in healthy humans chronic blueberry consumption leads to
sustained cardiovascular benefits which are linked with circulating anthocyanin metabolites and the modulation of cellular gene programs towards
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an anti-inflammatory and CVD protective profile. Future studies will help to further characterize the mechanisms-of-action of individual
metabolites, establish general structure-function relationships, and identify relevant interactions. As the identified metabolites are common for a
range of food bioactive classes, this knowledge represents an important building block necessary for the development of evidence based dietary
recommendations for food bioactives in primary prevention.
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TABLE 1: Composition of interventions used in human studies (ACN, anthocyanin).
 Control Control Control ACN Blueberry
  (+fiber) (fiber+minerals+vitamins)   
Dietary fiber (g)  5 5  4.4
Potassium (mg)   75  68
Fructose (g) 3.5 3.5 3.5 0.05 3.6
Total beta carotene (IU)   50  58
Vitamin C (mg)   12.5  1.7
Calcium (mg)   20  17
Iron (mg)   0.63  0.58
Vitamin E (IU)   1.88  0.39
Vitamin B1 (mg)   0.18  0.03
Vitamin B2 (mg)   0.19  0.01
Vitamin B6 (mg)   0.25  0.02
Phosphorus (mg)   15.6  12.9
Magnesium (mg)   12.5  6.5
Zinc (mg)   0.63  0.67
Manganese (mg)   2.25  2.87
Niacin (mg)   2.5  0.61
Anthocyanins (mg)    160 150
Flavanol monomers (mg)     3
Flavanol oligomers (mg)     49
Flavonols (mg)     31
Chlorogenic acid (mg)     64
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TABLE 2: Details of plasma metabolism from human (A) and animal (B) studies
A  Correlation (r) analysis human study B Estimated mouse plasma concentration (µM)
  2 h ∆FMD % 28 d ∆FMD %  2 h Metabolites 28 d Metabolites
 Cinnamic acids      
 Ferulic acid  0.51   0.1
 Ferulic acid-4-O-sulfate 0.36 0.43  1.6 1.2
 Ferulic acid 4-O-ß-D-glucuronide  0.44   2.8
 Isoferulic acid 3-O-sulfate  0.38  0.5 1.1
 Isoferulic acid 3-O-ß-D-glucuronide 0.43 0.48  1.0 1.5
 Dihydroferulic acid 0.54 0.43  1.1  
 Dihydroferulic acid 4-O-ß-D-glucuronide 0.42    0.1
 Dihydroisoferulic acid 3-O-ß-D-glucuronide  0.41   0.6
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 Dihydroisoferulic acid 3-O-sulfate  0.43   1.6
 Dihydrocaffeic acid 3-O-sulfate  0.63   0.1
 p-Coumaric  0.40   0.3
 Cinnamic acid  0.42  1.0  
 Chlorogenic acid 0.44  →   
 Benzoic acids    6.0 10.0
 Vanillic acid 0.60 0.61  0.9 1.4
 Homovanillic acid 0.40 0.52  0.3  
 Protocatechuic acid 0.37   0.1 0.2
 Syringic acid 0.41 0.42  0.4  
 4-Hydroxybenzoic acid 0.37    0.4
 2,4-Dihydroxybenzoic acd  0.64  0.8 0.5
 4-Methylgallic acid-3-O-sulfate 0.40 0.41    
 Phenols     12.7
 4-Methylcatechol-2-O-sulfate  0.42  0.9 1.8
 1-Methylpyrogallol-O-sulfate 0.62 0.50    
 Hippuric acids     368.9
 Hippuric acid  0.57   10.5
 3-Hydroxyhippuric acid  0.56    
 Phenylacetic acids     3.0
 3-Hydroxyphenyl acetic acid  0.46  3.0 5.0
 4-Hydroxyphenyl acetic acid 0.41 0.40    
 Flavonols    104.5  
 Quercetin 3-O-ß-D-glucuronide 0.38     
Note. A Univariate correlation between human plasma metabolites (study 4) and change in FMD at 2 h (2h FMD), ‘acute effect’) and after 28 days
(28 d FMD, ‘chronic effect’) of blueberry consumption in humans (values are Pearson’s r and all p<0.05) and B composition of metabolite mixes
that were injected intracardially in 100 Lvehicle into mice to demonstrate bioactivity of 2 h and 28 d metabolite profiles. Values represent
estimated instantaneous concentrations (mM) in mouse plasma. FMD is flow mediated dilatation, IC is intracardial
 
 
1
 
 
FIGURE LEGENDS
FIGURE 1: Importance of anthocyanin (ACN) in blueberry-mediated acute improvements in vascular function. Comparison of ACN effect
on flow-mediated dilation (FMD) with (A) other components of blueberry at 2 and 6 h  after ingestion (see TABLE 1 for composition of
interventions), (B) dose-response of ACN at 2 and 6 h (0 mg control arbitrarily set to 1), and (C) dose-response of blueberry at 2 h (adapted from
(12)). * p <0.05 vs 0 mg ACN control.
FIGURE 2: Circulating anthocyanin metabolites improve vascular function. (A) Pilot study to demonstrate time course of FMD during daily
consumption of blueberries. (B) FMD values at baseline after acute, chronic, and acute on chronic ingestion of control (white bars) and blueberry
(blue bars). In theses subjects a targeted metabolomics analysis of plasma metabolites was performed. We identified metabolites that correlated with
the 2h and day 28 changes (*see TABLE 2A for correlation analysis) and composed a chemically pure mix of the identified metabolites that we
injected intracardially into mice. (C) FMD in mice at before and after 15 min injection of mixtures of anthocyanin metabolite profiles that correlated
with of acute (2h) and chronic (28 days) FMD improvements in human study (*see TABLE 2B for composition).
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FIGURE 3: (A) Summary of individual stepwise regression analyses identifying circulating metabolites as significant independent predictors of
gene expression changes of the top 20 differentially expressed genes after 1 month of blueberry consumption (n=10). * designate that also
significant correlations existed with changes in flow-mediated dilation.  (B) Schematic illustration of biological processes and molecular functions
occuring in PBMC upon blueberry intake. A subset of genes from the 608 significant differentially expressed list were chosen for this figure as they
are involved in previously established cell processes which are highlighted in blue.
 
 
 
 
 
 
